e-learning
resources
Paris 2018
Monday, 17.09.2018
Lung cancer: novel prognostic markers and scores
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Association of tissue inhibitor of metalloproteinases 2 and 3 polymorphisms with non-small cell Lung cancer
Y. Lee (Taichung, Taiwan), C. Shih (Taichung, Taiwan)
Source:
International Congress 2018 – Lung cancer: novel prognostic markers and scores
Session:
Lung cancer: novel prognostic markers and scores
Session type:
Thematic Poster
Number:
2791
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Lee (Taichung, Taiwan), C. Shih (Taichung, Taiwan). Association of tissue inhibitor of metalloproteinases 2 and 3 polymorphisms with non-small cell Lung cancer. 2791
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
Related content which might interest you:
Association of genetic polymorphisms of matrix metalloproteinase (MMP)14 to the susceptibility of non-small cell lung cancer
Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Year: 2011
Tissue inhibitors of metalloproteinase-2 C-303T and G-418C genetic polymorphisms are associated with an increased risk of non-small cell lung cancer in Taiwan
Source: Annual Congress 2008 - Biology in thoracic tumours
Year: 2008
The association of cyclooxygenase 2 single-nucleotide polymorphisms with susceptibility to and severity of non-small cell lung cancer
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015
The association of MMP-7 and MMP-13 genetic polymorphisms with susceptibility to non-small cell lung cancer in Taiwan
Source: Annual Congress 2008 - Biology in thoracic tumours
Year: 2008
Association between H-RAS T81C genetic polymorphism with non-small cell Lung cancer
Source: Virtual Congress 2020 – Biological mechanisms of lung cancer
Year: 2020
Association of polymorphisms in the genes of the urokinase plasminogen activation system with susceptibility to and severity of nonsmall cell lung cancer
Source: Annual Congress 2009 - Lung cancer biology
Year: 2009
Association of Pre-miR-rs2910164 polymorphism with non-small cell lung cancer in an Iranian population
Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores
Year: 2018
Investigation of survivin gene polymorphism in non-small cell lung cancer patients (NSCLC)
Source: Annual Congress 2012 - New biomarkers for lung cancer
Year: 2012
A tissue microarray analysis on the role of chromosome 7 multiplication regarding the EGFR expression in non-small cell lung carcinomas
Source: International Congress 2016 – Molecular targets in pulmonary disease
Year: 2016
Association of KIR genes and their ligands with non-small cell lung cancer
Source: Annual Congress 2010 - Prognostic factors for lung cancer
Year: 2010
Cox-2 inhibitors in the treatment of small cell lung cancer patients
Source: International Congress 2015 – Advances in the therapy of lung cancer
Year: 2015
Simultaneous EGFR and VEGF alterations in non-small cell lung carcinoma based on tissue microarrays
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014
Proapoptotic effects of PAI-1 protein on lung and prostate cancer cells
Source: Annual Congress 2013 –Basic research on lung cancer
Year: 2013
Association of the endothelin-1 and endothelin A receptor genetic polymorphisms and non-small cell lung cancer in Taiwan
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016
Abnormal abundance of senescent fibroblasts in the tumor stroma of non-small cell lung cancer patients
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013
EGFRmutations are associated with higher brain metastasis radio-sensitivity than KRAS mutations or wild type EGFR in non-small cell lung cancer patients (NSCLC)
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014
Molecular signatures of non-small cell lung cancer (NSCLC) obtained from gene expression profiling of the benign bronchial mucosa of smokers with and without NSCLC
Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer
Year: 2013
Prognostic value of survivin gene promoter polymorphisms in non-small cell lung cancer
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016
A polymorphism, which exists intronic lesion of SLC5A10, affects DRG2 expression and survival outcome of early-stage non-small cell lung cancer
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015
Expression analysis of miR-21 in Bulgarian patients with non-small cell lung cancer
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept